Security key
30050B101
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)
CUSIP: 30050B101
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Class A Common Stock, par value $0.01 per share
- Total 13F shares
- 73,419,664
- Total 13F value
- $521,944,449
- Share change
- -2,360,376
- Put/Call ratio
- 141%
- SEC-reported price per share
- $7.12
- Number of holders
- 127
- Value change
- -$8,509,221
- Number of buys
- 64
- Number of sells
- 73
- Shares outstanding
- 112,318,617
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
127
Top holders
10
EVH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
Evolent Health, Inc. SEC filings
Evolent Health, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 30050B101
Recent filing periods:
Ownership snapshot
Top reported holders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 6.3%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 6.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
6.3%
JPMORGAN CHASE & CO
5.8%
BlackRock Finance, Inc.
5.1%
Bellevue Group AG
4.1%
DIMENSIONAL FUND ADVISORS LP
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
6.3%
|
$38,505,000
7,091,100 shares
|
— | 31 Mar 2020 |
| JPMORGAN CHASE & CO |
13F
Company
|
5.8%
|
$35,219,000
6,485,842 shares
|
— | 31 Mar 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
5.1%
|
$30,882,000
5,687,377 shares
|
— | 31 Mar 2020 |
| Bellevue Group AG |
13F
Company
|
4.1%
|
$24,872,000
4,580,458 shares
|
— | 31 Mar 2020 |
| DIMENSIONAL FUND ADVISORS LP |
13F
Company
|
3.4%
|
$20,715,000
3,814,741 shares
|
— | 31 Mar 2020 |
| CREDIT SUISSE AG/ |
13F
Company
|
3.3%
|
$20,326,000
3,743,238 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
127
Shares
73,419,664
Rows available
127
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
144
Q2 2020 holders
127
Holder diff
-17
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend